Kimberly McFee
Physician Assistant · Des Moines, IANPI 1720624182
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 10.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,506, 6.3 times the $240 reported in 2023. Among physician assistant clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 123 payments — averaging $20.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$263
- AstraZeneca$254
- Novartis$251
- Daiichi Sankyo Inc.$177
- Takeda Pharmaceuticals U.S.A., Inc.$147
- Deciphera Pharmaceuticals Inc.$109
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,45396%
- Education$1004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 10 | $263 |
| AstraZeneca | 12 | $254 |
| Novartis | 16 | $251 |
| Daiichi Sankyo Inc. | 8 | $177 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $147 |
| Deciphera Pharmaceuticals Inc. | 5 | $109 |
| Merck | 4 | $97 |
| Array Biopharma Inc | 5 | $96 |
| Stemline Therapeutics Inc. | 5 | $95 |
| Eisai Inc. | 4 | $91 |
| GSK | 4 | $85 |
| Pfizer | 4 | $84 |
| Puma Biotechnology, Inc. | 4 | $81 |
| Pharmaessentia USA Corporation | 4 | $80 |
| Gilead | 3 | $67 |
| AbbVie | 3 | $61 |
| Azurity Pharmaceuticals, Inc. | 2 | $57 |
| Incyte Corporation | 3 | $55 |
| Sanofi | 2 | $50 |
| Bayer | 2 | $42 |
| Genmab U.S., Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $36 |
| Tactile Systems Technology Inc | 1 | $33 |
| Recordati_rare_diseases_inc. | 1 | $24 |
| Beigene USA, Inc. | 1 | $23 |
| Tersera Therapeutics LLC | 1 | $22 |
| Syndax Pharmaceuticals, Inc. | 1 | $22 |
| Rigel Pharmaceuticals, Inc. | 1 | $21 |
| Seagen Inc. | 1 | $17 |
| Pharmacosmos Therapeutics Inc. | 1 | $16 |
| Blueprint Medicines Corporation | 1 | $16 |
| Beone Medicines USA, Inc. | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| CTI Biopharma Corp. | 1 | $13 |
How this compares
$2,553 in reported general payments places this provider in the 90th percentile of 1,140 physician assistant providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 73 | $1,130 |
| Tamoxifen Citrate | 26 | $836 |
| Letrozole | 16 | $539 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 16 | $215 |
| Prochlorperazine Maleate | 13 | $195 |
| Gabapentin | 17 | $161 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Des Moines
- Lindsey HuismanDes Moines$7K
- David RobertsDes Moines$5K
- Anthony UrbanskiDes Moines$3K
- Jayson GesulgaUrbandale$878K
- Laurie ClairJohnston$293K
- Katherine LemAmes$224K
- Laura CunninghamWest Des Moines$128K
- Michon LeddyClive$73K
- Kyle HawkinsIowa City$42K
- Andrew MetzgerIowa City$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.